These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 23372169

  • 1. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes.
    Currie CJ, Poole CD, Evans M, Peters JR, Morgan CL.
    J Clin Endocrinol Metab; 2013 Feb; 98(2):668-77. PubMed ID: 23372169
    [Abstract] [Full Text] [Related]

  • 2. Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial.
    Ghotbi AA, Køber L, Finer N, James WP, Sharma AM, Caterson I, Coutinho W, Van Gaal LF, Torp-Pedersen C, Andersson C.
    Diabetes Care; 2013 Nov; 36(11):3746-53. PubMed ID: 24089540
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline.
    Hung AM, Roumie CL, Greevy RA, Grijalva CG, Liu X, Murff HJ, Ikizler TA, Griffin MR.
    Clin J Am Soc Nephrol; 2016 Dec 07; 11(12):2177-2185. PubMed ID: 27827311
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.
    Johnson JA, Majumdar SR, Simpson SH, Toth EL.
    Diabetes Care; 2002 Dec 07; 25(12):2244-8. PubMed ID: 12453968
    [Abstract] [Full Text] [Related]

  • 7. Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study.
    Andersson C, Olesen JB, Hansen PR, Weeke P, Norgaard ML, Jørgensen CH, Lange T, Abildstrøm SZ, Schramm TK, Vaag A, Køber L, Torp-Pedersen C, Gislason GH.
    Diabetologia; 2010 Dec 07; 53(12):2546-53. PubMed ID: 20838985
    [Abstract] [Full Text] [Related]

  • 8. What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes.
    Morgan CL, Poole CD, Evans M, Barnett AH, Jenkins-Jones S, Currie CJ.
    J Clin Endocrinol Metab; 2012 Dec 07; 97(12):4605-12. PubMed ID: 23076348
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.
    Roumie CL, Greevy RA, Grijalva CG, Hung AM, Liu X, Murff HJ, Elasy TA, Griffin MR.
    JAMA; 2014 Jun 11; 311(22):2288-96. PubMed ID: 24915260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
    Roumie CL, Hung AM, Greevy RA, Grijalva CG, Liu X, Murff HJ, Elasy TA, Griffin MR.
    Ann Intern Med; 2012 Nov 06; 157(9):601-10. PubMed ID: 23128859
    [Abstract] [Full Text] [Related]

  • 16. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J, Mehta R, Donnelly R, Idris I.
    Ann Med; 2016 Nov 06; 48(4):224-34. PubMed ID: 26982210
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes.
    Anyanwagu U, Mamza J, Mehta R, Donnelly R, Idris I.
    Heart; 2016 Oct 01; 102(19):1581-7. PubMed ID: 27217068
    [Abstract] [Full Text] [Related]

  • 18. Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus.
    Eurich DT, Simpson SH, Majumdar SR, Johnson JA.
    Pharmacotherapy; 2005 Jun 01; 25(6):810-6. PubMed ID: 15927899
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.